Cargando…
Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/ https://www.ncbi.nlm.nih.gov/pubmed/32555299 http://dx.doi.org/10.1038/s41598-020-66945-3 |
_version_ | 1783547978933338112 |
---|---|
author | Sato, Hiroe Takai, Chinatsu Kazama, Junichiro James Wakamatsu, Ayako Hasegawa, Eriko Kobayashi, Daisuke Kondo, Naoki Nakatsue, Takeshi Abe, Asami Ito, Satoshi Ishikawa, Hajime Kuroda, Takeshi Suzuki, Yoshiki Narita, Ichiei |
author_facet | Sato, Hiroe Takai, Chinatsu Kazama, Junichiro James Wakamatsu, Ayako Hasegawa, Eriko Kobayashi, Daisuke Kondo, Naoki Nakatsue, Takeshi Abe, Asami Ito, Satoshi Ishikawa, Hajime Kuroda, Takeshi Suzuki, Yoshiki Narita, Ichiei |
author_sort | Sato, Hiroe |
collection | PubMed |
description | Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteoporosis in patients with rheumatoid arthritis (RA). A total of 262 patients with RA (67.5 ± 11.4 years; 77.5% female) were enrolled. Serum iron, ferritin, and hepcidin levels were positively correlated each other. Multiple regression analyses revealed that the serum iron level was positively correlated with femoral T and Z scores, whereas the serum hepcidin level was not. Serum hepcidin level was correlated with the serum 25-hydroxy vitamin D level, which was in turn positively related to the femoral Z score. Serum hepcidin and serum iron were indirectly and directly related to osteoporosis in patients with RA. |
format | Online Article Text |
id | pubmed-7303107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73031072020-06-22 Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis Sato, Hiroe Takai, Chinatsu Kazama, Junichiro James Wakamatsu, Ayako Hasegawa, Eriko Kobayashi, Daisuke Kondo, Naoki Nakatsue, Takeshi Abe, Asami Ito, Satoshi Ishikawa, Hajime Kuroda, Takeshi Suzuki, Yoshiki Narita, Ichiei Sci Rep Article Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteoporosis in patients with rheumatoid arthritis (RA). A total of 262 patients with RA (67.5 ± 11.4 years; 77.5% female) were enrolled. Serum iron, ferritin, and hepcidin levels were positively correlated each other. Multiple regression analyses revealed that the serum iron level was positively correlated with femoral T and Z scores, whereas the serum hepcidin level was not. Serum hepcidin level was correlated with the serum 25-hydroxy vitamin D level, which was in turn positively related to the femoral Z score. Serum hepcidin and serum iron were indirectly and directly related to osteoporosis in patients with RA. Nature Publishing Group UK 2020-06-18 /pmc/articles/PMC7303107/ /pubmed/32555299 http://dx.doi.org/10.1038/s41598-020-66945-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Sato, Hiroe Takai, Chinatsu Kazama, Junichiro James Wakamatsu, Ayako Hasegawa, Eriko Kobayashi, Daisuke Kondo, Naoki Nakatsue, Takeshi Abe, Asami Ito, Satoshi Ishikawa, Hajime Kuroda, Takeshi Suzuki, Yoshiki Narita, Ichiei Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title | Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title_full | Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title_fullStr | Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title_full_unstemmed | Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title_short | Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
title_sort | serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/ https://www.ncbi.nlm.nih.gov/pubmed/32555299 http://dx.doi.org/10.1038/s41598-020-66945-3 |
work_keys_str_mv | AT satohiroe serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT takaichinatsu serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT kazamajunichirojames serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT wakamatsuayako serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT hasegawaeriko serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT kobayashidaisuke serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT kondonaoki serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT nakatsuetakeshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT abeasami serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT itosatoshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT ishikawahajime serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT kurodatakeshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT suzukiyoshiki serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis AT naritaichiei serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis |